CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to commercialize a personalized tissue-engineered vein for treating severe Chronic Venous Insufficiency, a condition with no effective treatment. The technology utilizes decellularized donor tissue seeded with the patient's own cells to create a graft that avoids transplant rejection.
This project will commercialize P-TEV - a unique personalized tissue engineered vein for the treatment of patients with severe Chronic Venous Insufficiency (CVI).CVI is a progressive medical condition in which the valves of the deep veins of the leg are not functioning properly.
The most severe stage is CVI with leg ulceration.
No effective treatment is available, and a large number of patients would directly benefit from venous vascular surgery.
These patients cannot be cured today because no s…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
